Chiral Columns for Oligonucleotides Analysis (Nov 2023)
Accurate purity assessment of oligonucleotide mixtures can be challenging due to their complexity. Daicel offers several solutions that provide unique selectivity.
Impurity Analysis of Synthetic Cyclic Peptides (Sept 2023)
Complementarity in chromatography ensures accurate purity. Daicel offers non-chiral stationary phases compatible in different modes for cyclic peptide analysis.
Impurity Analysis of Synthetic Cyclic Peptides (July 2023)
Chiral Columns for Oligonucleotides Analysis
Impurity Analysis of Synthetic Cyclic Peptides
Chiral Resolution of Sotorasib Atropisomers
Daicel Chiral Technologies' unique HPLC and SFC chiral stationary phases are capable of separating the most challenging compounds, like the atropisomers of Sotorasib.
Chiral Resolution of Mecoprop Enantiomers on CHIRALPAK IM
Application note demonstrating the improved chiral separation of herbicide mecoprop by use of an immobilized column that allows usage of a wider range of solvents
The Chiral Resolution of Fluoxetine (Sept 2022)
This application note is the first reported separation of Fluoxetine on polysaccharide-based chiral HPLC columns, and it comes on Daicel’s newest column, CHIRALPAK® IK.
Application Note: Separation of Mirtazapine on CHIRALPAK® IK-3 (July 15, 2022)
Application Note: Separation of Mirtazapine on CHIRALPAK® IK-3
Separation of Mirtazapine on CHIRALPAK® IK-3
Mirtazapine is an approved antidepressant, with other studies exploring its use to treat sleep apnea, substance abuse withdrawal symptoms, and as an antihistamine.
Application Note: The Chiral Resolution of Fluoxetine
The Chiral Resolution of Fluoxetine
